PRESS RELEASE published on 10/31/2024 at 10:20, 1 year 6 months ago Changement au Conseil d’Administration Nomination du Dr Ian Gilham au poste d’administrateur non exécutif chez Novacyt. Son expertise renforcera le conseil d'administration de la société Conseil D'administration Santé Diagnostic Moléculaire Novacyt Dr Ian Gilham
BRIEF published on 10/17/2024 at 11:47, 1 year 6 months ago Certification IVDR pour le test Yourgene® de la mucoviscidose par Novacyt Dépistage Novacyt IVDR Mucoviscidose Yourgene
BRIEF published on 10/17/2024 at 11:47, 1 year 6 months ago IVDR Certification for Yourgene® Cystic Fibrosis Test by Novacyt Screening Novacyt IVDR Cystic Fibrosis Yourgene
PRESS RELEASE published on 10/17/2024 at 11:42, 1 year 6 months ago Certification IVDR obtenue pour le test de référence Yourgene® de la mucoviscidose Novacyt obtient la certification IVDR pour le test de mucoviscidose Yourgene®. Le test est conforme aux normes de qualité et de sécurité européennes, essentiel pour le dépistage de la mucoviscidose Dépistage Novacyt Mucoviscidose Yourgene Certification IVDR
BRIEF published on 10/10/2024 at 12:28, 1 year 6 months ago Novacyt ferme sa filiale IT-IS International EBITDA Fermeture Novacyt IT-IS International PCR Marché
BRIEF published on 10/10/2024 at 12:28, 1 year 6 months ago Novacyt closes its IT-IS International subsidiary EBITDA Closing Novacyt IT-IS International PCR Market
BRIEF published on 10/10/2024 at 12:27, 1 year 6 months ago Novacyt Closes IT-IS International Subsidiary Amid Market Saturation Financial Impact Intellectual Property Novacyt PCR Market IT-IS Closure
BRIEF published on 10/10/2024 at 12:27, 1 year 6 months ago Novacyt ferme sa filiale IT-IS International dans un contexte de saturation du marché Propriété Intellectuelle Impact Financier Novacyt Clôture De L'IT-IS Marché De La PCR
PRESS RELEASE published on 10/10/2024 at 12:23, 1 year 6 months ago Fermeture d’IT-IS International Novacyt annonce la fermeture d’IT-IS International, filiale acquise en 2020, pour améliorer sa position financière. Litige en cours avec Roche Diagnostics GmbH préservé Fermeture Litige Novacyt IT-IS International Roche Diagnostics GmbH
PRESS RELEASE published on 10/10/2024 at 12:22, 1 year 6 months ago Closure of IT-IS International Novacyt announces closure of IT-IS International subsidiary to improve EBITDA. Retains IP for ongoing dispute with Roche Diagnostics. Focus on future growth and cost reduction EBITDA Closure Novacyt IT-IS International IP Dispute
Published on 05/08/2026 at 00:45, 48 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 1 hour 33 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 2 hours 3 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 2 hours 18 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 3 hours 28 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 23:23, 2 hours 9 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 2 hours 19 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 3 hours 28 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 4 hours 51 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 6 hours 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 6 hours 18 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 6 hours 18 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 6 hours 27 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 6 hours 27 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 6 hours 33 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
